Poly(ala) is designed to mimic the structure and function of myelin basic protein (MBP) in order to modulate and suppress immune responses specifically related to myelin antigens. This polymer, created from a precise combination of amino acids, binds to MHC class II molecules, which helps it compete with myelin antigens for T-cell activation and induces the formation of specific Th2 suppressor cells. This antigen-specific action reduces the likelihood of long-term immune system damage by effectively inhibiting T-cell responses to MBP and other related antigens. The result is a significant reduction in relapse rates, particularly benefiting patients with minimal accumulated neurological disability.